Evidence map›Paper›PMID 38251365›Full record

ReviewPathogens (Basel, Switzerland)2024

Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases.

Jonathan M Banks, Kristelle J Capistrano, Daniela A Brandini, Filza Zaidi, Pari Thakkar, Rani Rahat, Joel Schwartz, Afsar R Naqvi

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Virulence · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Oral SARS-CoV-2 Infection and Risk for Long Covid.Reviews in medical virology · 2025
    Review
  8. Effects of Herpesviruses on Proinflammatory Cytokines in Chronic Periapical Lesions.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jonathan M BanksDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Kristelle J CapistranoDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.ORCID 0000-0003-4349-9924
Daniela A BrandiniDepartment of Diagnosis and Surgery, School of Dentistry, São Paulo State University (UNESP), Araçatuba 16015-050, SP, Brazil.
Filza ZaidiDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Pari ThakkarDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Rani RahatDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Joel SchwartzDepartment of Oral Medicine and Diagnostics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Afsar R NaqviDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
University of Illinois Chicago · USUniversidade Estadual Paulista (Unesp) · BR

Funding

A new molecular therapy against ocular herpesR01EY024710 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DEEPAK SHUKLA · 2015 to 2026
$5.2M
Human Herpesvirus Impact on Periodontal InflammationR01DE027980 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NAQVI, AFSAR RAZA · 2018 to 2022
$1.9M
Mechanisms of Immune Dysfunction in Oral Post-Acute Sequelae of Covid-19R56DE033249 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NAQVI, AFSAR RAZA, RICHNER, JUSTIN · 2023 to 2023
$581k
NEI NIH HHS R01 EY024710NIDCR NIH HHS R01 DE027980NIDCR NIH HHS R56 DE033249NIH HHS R56DE033249NIH HHS RO1DE027980NIH HHS RO1EY024710
6 · The paper itself

Abstract

The oral cavity is a niche for diverse microbes, including viruses. Members of the Herpesviridae family, comprised of dsDNA viruses, as well as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an ssRNA virus, are among the most prevalent viruses infecting the oral cavity, and they exhibit clinical manifestations unique to oral tissues. Viral infection of oral mucosal epithelia triggers an immune response that results in prolonged inflammation. The clinical and systemic disease manifestations of HHV have been researched extensively, and several recent studies have illuminated the relationship between HHV and oral inflammatory diseases. Burgeoning evidence suggests the oral manifestation of SARS-CoV-2 infection includes xerostomia, dysgeusia, periodontal disease, mucositis, and opportunistic viral and bacterial infections, collectively described as oral post-acute sequelae of COVID-19 (PASC). These diverse sequelae could be a result of intensified immune responses initially due to the copious production of proinflammatory cytokines: the so-called "cytokine storm syndrome", facilitating widespread oral and non-oral tissue damage. This review explores the interplay between HHV, SARS-CoV-2, and oral inflammatory diseases such as periodontitis, endodontic disease, and peri-implantitis. Additionally, the review discusses proper diagnostic techniques for identifying viral infection and how viral diagnostics can lead to improved overall patient health.

Indexed as

COVID-19HerpesviridaeHerpesviridae InfectionsSARS-CoV-2Cytokine Release SyndromeHumansInflammationMouth Diseasesendodontic diseasegingivitisherpesvirusoral inflammationperi-implantitisperiodontitisSARS-CoV-2viral diagnostics

Identifiers

PMID38251365
PMCPMC10819702
OpenAlexW4390672434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.